Jeffrey Jensen

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. doi request reprint Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms
    Jeffrey T Jensen
    Oregon Health and Science University, Department of Ob Gyn, UHN 70, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA
    Expert Opin Pharmacother 9:319-27. 2008
  2. ncbi request reprint Blockade of tubal patency following transcervical administration of polidocanol foam: initial studies in rhesus macaques
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University OHSU, Portland, OR, USA Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR, USA Electronic address
    Contraception 89:540-9. 2014
  3. pmc Vaginal ring delivery of selective progesterone receptor modulators for contraception
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 87:314-8. 2013
  4. doi request reprint Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies
    Jeffrey Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 87:107-12. 2013
  5. doi request reprint Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239 2941, USA
    Contraception 86:110-8. 2012
  6. doi request reprint Cost burden and treatment patterns associated with management of heavy menstrual bleeding
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Women s Health Research Unit, Portland, Oregon 97239, USA
    J Womens Health (Larchmt) 21:539-47. 2012
  7. pmc Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques
    Carol B Hanna
    Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health and Science University, West Campus, Beaverton, OR 97006, USA
    Reprod Biol Endocrinol 8:150. 2010
  8. pmc Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 81:165-71. 2010
  9. ncbi request reprint The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation during gonadotropin-stimulated ovarian cycles in rhesus macaques
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology and Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 71:68-73. 2005
  10. ncbi request reprint Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study
    J T Jensen
    Department of Obstetrics and Gynecology, Oregon Health Sciences University, Portland 97201, USA
    Contraception 59:153-9. 1999

Collaborators

Detail Information

Publications66

  1. doi request reprint Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms
    Jeffrey T Jensen
    Oregon Health and Science University, Department of Ob Gyn, UHN 70, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA
    Expert Opin Pharmacother 9:319-27. 2008
    ....
  2. ncbi request reprint Blockade of tubal patency following transcervical administration of polidocanol foam: initial studies in rhesus macaques
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University OHSU, Portland, OR, USA Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR, USA Electronic address
    Contraception 89:540-9. 2014
    ..To demonstrate the feasibility of polidocanol foam (PF) as a nonsurgical method of female permanent contraception using a nonhuman primate model...
  3. pmc Vaginal ring delivery of selective progesterone receptor modulators for contraception
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 87:314-8. 2013
    ..Results from Phase 1 and 2 studies demonstrate that suppression of ovulation occurs with UPA levels above 6-7 ng/mL...
  4. doi request reprint Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies
    Jeffrey Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 87:107-12. 2013
    ..The reduction in menstrual blood loss volume has been well documented elsewhere...
  5. doi request reprint Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239 2941, USA
    Contraception 86:110-8. 2012
    ..The bleeding patterns of two variants of a flexible dosing regimen designed to manage intracyclic bleeding problems during extended cycles were compared with that of a conventional OC regimen...
  6. doi request reprint Cost burden and treatment patterns associated with management of heavy menstrual bleeding
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Women s Health Research Unit, Portland, Oregon 97239, USA
    J Womens Health (Larchmt) 21:539-47. 2012
    ..This study evaluated the healthcare resource use, work productivity loss, costs, and treatment patterns associated with newly diagnosed idiopathic heavy menstrual bleeding (HMB) using a large employer database...
  7. pmc Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques
    Carol B Hanna
    Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health and Science University, West Campus, Beaverton, OR 97006, USA
    Reprod Biol Endocrinol 8:150. 2010
    ....
  8. pmc Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 81:165-71. 2010
    ..The study was conducted to determine whether a phosphodiesterase (PDE) 3 inhibitor has potential as a novel contraceptive in primates...
  9. ncbi request reprint The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation during gonadotropin-stimulated ovarian cycles in rhesus macaques
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology and Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 71:68-73. 2005
    ..These results demonstrate that the PDE3 inhibitor ORG 9935 blocks oocyte maturation during gonadotropin-stimulated ovarian cycles in rhesus macaques and suggest that PDE3 inhibitors have potential clinical use as contraceptives in women...
  10. ncbi request reprint Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study
    J T Jensen
    Department of Obstetrics and Gynecology, Oregon Health Sciences University, Portland 97201, USA
    Contraception 59:153-9. 1999
    ..They experience more discomfort with their procedure and in the follow-up interval, bleed for a longer period, and remain at risk for surgical completion curettage for several weeks...
  11. ncbi request reprint Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, UHN 70, Oregon Health and Science University, 3181 Sam Jackson Park Road, Portland, OR 97239, USA
    Obstet Gynecol Surv 60:604-12. 2005
    ....
  12. doi request reprint A continuous regimen of levonorgestrel/ethinyl estradiol for contraception and elimination of menstruation
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Drugs Today (Barc) 44:183-95. 2008
    ..Control of cycle-related symptoms may emerge as an off-label indication for use...
  13. pmc Use of controlled ovulation of the dominant follicle to assess oocyte maturation during natural menstrual cycles in rhesus macaques
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon 97239, USA
    Fertil Steril 87:1477-9. 2007
    ..All of the oocytes (3/3) recovered from control animals, but only 1/6 (17%) of oocytes from animals treated with the meiotic inhibitor ORG 9935 exhibited germinal vesicle breakdown, indicating resumption of meiosis...
  14. ncbi request reprint Subject and clinician experience with the levonorgestrel-releasing intrauterine system
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 77:22-9. 2008
    ....
  15. doi request reprint Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest
    Jeffrey T Jensen
    Oregon Health and Science University, Department of Obstetrics and Gynecology, UHN 70, OHSU, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA
    Expert Opin Pharmacother 11:1147-57. 2010
    ..Since ethinyl estradiol is a potent activator of hepatic enzymes, the use of natural estradiol (E2) has been studied; but, until recently, bleeding control has hampered development of an E2 pill...
  16. doi request reprint Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon 97239, USA
    Obstet Gynecol 117:777-87. 2011
    ....
  17. ncbi request reprint Transcervical polidocanol as a nonsurgical method of female sterilization: a pilot study
    J T Jensen
    Division of Reproductive Sciences, Oregon Regional Primate Research Center, Department of Obstetrics and Gynecology Oregon Health and Science University, Portland, OR, USA
    Contraception 70:111-5. 2004
    ..Experiments using a primate model are needed as proof of concept prior to human studies of candidate agents for transcervical tubal sterilization...
  18. ncbi request reprint Health benefits of oral contraceptives
    J T Jensen
    Department of Obstetrics and Gynecology, Oregon Health Sciences University, Portland, USA
    Obstet Gynecol Clin North Am 27:705-21. 2000
    ..Getting the good news out about the benefits of oral contraceptives will enable more women to take advantage of their positive health effects...
  19. ncbi request reprint Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro
    J T Jensen
    Department of Obstetrics and Gynecology and Division of Reproductive Sciences, Oregon Regional Primate Research Center, Oregon Health and Science University, Portland, OR 97201, USA
    Hum Reprod 17:2079-84. 2002
    ..The purpose of this study was to determine whether phosphodiesterase (PDE) 3 inhibitors selectively prevent the resumption of meiosis in primates...
  20. ncbi request reprint Noncontraceptive applications of the levonorgestrel intrauterine system
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Mail Code L 466, Oregon Health and Science University, Portland, OR 97201, USA
    Curr Womens Health Rep 2:417-22. 2002
    ..The device also provides endometrial protection in combination with estrogen as postmenopausal hormone replacement therapy. In this paper, the growing literature on the emerging noncontraceptive indications for the LNG-IUS is reviewed...
  21. pmc Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 78:451-8. 2008
    ..The study was conducted to determine the impact of switching from oral to transdermal patch or vaginal ring contraception on biomarkers of thrombosis...
  22. doi request reprint Why family planning matters
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Rev Endocr Metab Disord 12:55-62. 2011
    ..This paper discusses the interaction between population growth and the environment, and reviews modern methods of contraception...
  23. ncbi request reprint Quality of life and sexual function after evaluation and treatment at a referral center for vulvovaginal disorders
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, 97201, USA
    Am J Obstet Gynecol 188:1629-35; discussion 1635-7. 2003
    ..This study was undertaken to assess sexual function and quality of life of women after evaluation and treatment of vulvovaginal problems at a University Center...
  24. pmc Human embryonic stem cells derived by somatic cell nuclear transfer
    Masahito Tachibana
    Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health and Science University, 505 NW 185th Avenue, Beaverton, OR 97006, USA
    Cell 153:1228-38. 2013
    ..Gene expression and differentiation profiles in human NT-ESCs were similar to embryo-derived ESCs, suggesting efficient reprogramming of somatic cells to a pluripotent state...
  25. doi request reprint A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use
    Bliss Kaneshiro
    Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, HI 96826, USA
    Contraception 85:351-8. 2012
    ..The study objective was to determine if prophylactic administration of doxycycline (an MMP inhibitor at low subantimicrobial doses) would prevent unscheduled bleeding during the initiation of a continuous OCP...
  26. doi request reprint Treatment of unscheduled bleeding in continuous oral contraceptive users with doxycycline: a randomized controlled trial
    Bliss Kaneshiro
    Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, Hawaii 96826, USA
    Obstet Gynecol 115:1141-9. 2010
    ..To estimate whether doxycycline, a matrix metalloproteinase inhibitor, would decrease unscheduled bleeding associated with initiation of a continuous oral contraceptive pill...
  27. doi request reprint Unscheduled bleeding with continuous oral contraceptive pills: a comparison of progestin dose
    Bliss Kaneshiro
    Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, HI 96826, USA
    Contraception 86:22-7. 2012
    ..The objective of this study was to determine whether progestin dose influences bleeding with use of continuous OCPs...
  28. ncbi request reprint Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial
    Marni Kwiecien
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Mail Code L 466, Portland, OR 97201, USA
    Contraception 67:9-13. 2003
    ..The continuous group had fewer light and moderate bleeding days, less bloating and menstrual pain. For patients who are seeking these results, this method may be more desirable...
  29. doi request reprint The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth
    Bliss Kaneshiro
    Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, HI 96826, USA
    Contraception 77:234-8. 2008
    ..The study was conducted to characterize the relationship between body mass index (BMI) and unintended pregnancy, contraceptive use patterns, and perceived fertility...
  30. pmc Online availability of hormonal contraceptives without a health care examination: effect of knowledge and health care screening
    Alexa P Kaskowitz
    Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 76:273-7. 2007
    ..The study was conducted to investigate whether the knowledge of women using an online resource to obtain hormonal contraceptives (HCs) without a health care examination is similar to women who obtain HC in the clinic...
  31. pmc The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation in the naturally selected dominant follicle in rhesus macaques
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 77:303-7. 2008
    ..The study was conducted to determine whether the phosphodiesterase (PDE) 3 inhibitor ORG 9935 prevents the resumption of meiosis in primate oocytes during natural menstrual cycles...
  32. doi request reprint Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, FL 32209, USA
    Contraception 86:452-7. 2012
    ..We compared the effects of the levonorgestrel-releasing intrauterine system (LNG-IUS) with cyclic oral medroxyprogesterone acetate (MPA) on hemoglobin and serum ferritin levels in women with heavy menstrual bleeding (HMB)...
  33. doi request reprint Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion
    Ann M Stanek
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 79:216-20. 2009
    ..The aim of the study was to identify barriers associated with the failure to return for delayed intrauterine device (IUD) insertion postabortion...
  34. pmc Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity
    Alison B Edelman
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 80:119-27. 2009
    ..This study was conducted to determine whether increased body mass index (BMI) affects oral contraceptive (OC) pharmacokinetics and suppression of hypothalamic-pituitary-ovarian (HPO) axis activity...
  35. pmc Group B streptococcus: prevalence in a non-obstetric population
    Catherine M Leclair
    Department of Obstetrics and Gynecology, Oregon Health and Sciences University, Portland, OR 97239, USA
    J Low Genit Tract Dis 14:162-6. 2010
    ..To establish and compare the prevalence of group B streptococcus (GBS) colonization in the vaginas of nonobstetric women with and without vaginitis...
  36. pmc A nonhormonal model for emergency contraception: prostaglandin synthesis inhibitor effects on luteal function and lifespan, a pilot study
    Alison B Edelman
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon 97239, USA
    Contraception 81:496-500. 2010
    ..The purpose of this study is to determine if the use of a specific prostaglandin endoperoxide-2 inhibitor will prevent luteal development in women...
  37. doi request reprint Pain control in first-trimester surgical abortion: a systematic review of randomized controlled trials
    Regina M Renner
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 81:372-88. 2010
    ..First-trimester abortions especially cervical dilation and suction aspiration are associated with pain despite various methods of pain control...
  38. ncbi request reprint Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Alison B Edelman
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon 97239, USA
    Obstet Gynecol 107:657-65. 2006
    ..To estimate whether progestin type or estrogen dose influences bleeding patterns, adverse effects, or satisfaction with combined oral contraceptives dosed continuously...
  39. ncbi request reprint Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results
    David F Archer
    CONRAD Clinical Research Center, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA
    Contraception 74:439-45. 2006
    ..This study was conducted to evaluate the safety and efficacy of a continuous daily regimen of levonorgestrel (LNG) 90 microg/ethinyl estradiol (EE) 20 microg (continuous LNG/EE)...
  40. pmc A comparison of blood spot vs. plasma analysis of gonadotropin and ovarian steroid hormone levels in reproductive-age women
    Alison Edelman
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon 97239, USA
    Fertil Steril 88:1404-7. 2007
    ..To compare LH, FSH, P, and E(2) levels obtained from blood spot vs. plasma (single-visit study) and to determine whether blood spots can document circulating hormone levels during ovulatory cycles (menstrual-cycle study)...
  41. ncbi request reprint Four percent intrauterine lidocaine infusion for pain management in first-trimester abortions
    Alison Edelman
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, 97239, USA
    Obstet Gynecol 107:269-75. 2006
    ..To study the effects of a 4% intrauterine lidocaine infusion on perceived patient pain in first-trimester abortions...
  42. ncbi request reprint Characteristics and initial diagnoses in women presenting to a referral center for vulvovaginal disorders in 1996-2000
    Amy Hansen
    School of Medicine, Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, USA
    J Reprod Med 47:854-60. 2002
    ..To describe the demographics, presenting symptoms, physical examination and laboratory findings, and initial diagnoses in a cohort of women referred for evaluation of vulvovaginal problems...
  43. ncbi request reprint Comparing bimanual pelvic examination to ultrasound measurement for assessment of gestational age in the first trimester of pregnancy
    Mark Nichols
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA
    J Reprod Med 47:825-8. 2002
    ..To compare the accuracy of bimanual pelvic examination to ultrasound in the assessment of gestational age and to evaluate resident and faculty accuracy, and residents' learning to perform pelvic examination...
  44. ncbi request reprint Intrauterine lidocaine infusion for pain management in first-trimester abortions
    Alison Edelman
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Obstet Gynecol 103:1267-72. 2004
    ..To study the effects of an intrauterine lidocaine infusion on perceived patient pain in first-trimester abortions and to measure serum lidocaine levels...
  45. ncbi request reprint KTP-nd:YAG laser therapy for the treatment of vestibulodynia: a follow-up study
    Catherine M Leclair
    Program in Vulvar Health, Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, USA
    J Reprod Med 52:53-8. 2007
    ..To evaluate the results of KTP-Nd:YAG laser therapy for the treatment of vestibulodynia...
  46. doi request reprint Effect of "observed start" vs. traditional "Sunday start" on hormonal contraceptive continuation rates after medical abortion
    Paula H Bednarek
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 78:26-30. 2008
    ....
  47. ncbi request reprint Successful medical abortion of a pregnancy within a noncommunicating rudimentary uterine horn
    Alison B Edelman
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland 97239, USA
    Am J Obstet Gynecol 189:886-7. 2003
    ..We present a case of a successful pregnancy termination of a gestation located in a noncommunicating rudimentary horn with subsequent elective laparoscopic resection...
  48. ncbi request reprint Copper T380A intrauterine device: lost and found
    Bliss Kaneshiro
    Department of Obstetrics and Gynecology, University of Hawai i, Honolulu, HI 96826, USA
    Hawaii Med J 67:131-2. 2008
  49. ncbi request reprint Patient satisfaction and the impact of written material about postpartum contraceptive decisions
    Lisa K Johnson
    Department of Obstetrics and Gynecology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road L466, Portland, OR 97201, USA
    Am J Obstet Gynecol 188:1202-4. 2003
    ..The purpose of this study was to evaluate the impact of written educational material about patient satisfaction and decision-making regarding postpartum contraception...
  50. ncbi request reprint Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women
    Alison Edelman
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 75:450-3. 2007
    ..The study was conducted to determine women's preferences about menstrual bleeding patterns and their willingness to manipulate bleeding with contraception...
  51. pmc Medical termination of pregnancy in cynomolgus macaques
    Elizabeth Micks
    Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195 6460, USA
    J Med Primatol 41:394-402. 2012
    ..As the macaque cervix does not facilitate transcervical surgical termination of pregnancy, we sought to establish a medical termination protocol...
  52. doi request reprint Blood loss at the time of first-trimester surgical abortion in anticoagulated women
    Bliss Kaneshiro
    Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, HI 96826, USA
    Contraception 83:431-5. 2011
    ..The objective of this study was to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks of gestation between women receiving anticoagulation therapy and healthy controls...
  53. ncbi request reprint Women's knowledge and sources of information on the risks and benefits of oral contraception
    Carla M Picardo
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, USA
    J Am Med Womens Assoc 58:112-6. 2003
    ..To assess the knowledge of the risks and benefits of oral contraceptives (OCs) in a heterogeneous group of women and to identify their sources of information...
  54. ncbi request reprint Patient satisfaction after the treatment of vulvovaginal erosive lichen planus with topical clobetasol and tacrolimus: a survey study
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, USA
    Am J Obstet Gynecol 190:1759-63; discussion 1763-5. 2004
    ..The purpose of this study was to compare patient satisfaction with the topical immune system modulator tacrolimus to topical clobetasol during treatment for vulvovaginal erosive lichen planus...
  55. pmc WEE2 is an oocyte-specific meiosis inhibitor in rhesus macaque monkeys
    Carol B Hanna
    Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health and Science University, West Campus, 505 NW 185th Avenue, Beaverton, OR 97006, USA
    Biol Reprod 82:1190-7. 2010
    ..These findings suggest that WEE2 is a conserved oocyte-specific meiosis inhibitor that functions downstream of cAMP in nonhuman primates...
  56. doi request reprint Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, Florida, USA
    Obstet Gynecol 116:625-32. 2010
    ..To compare the efficacy and safety of the levonorgestrel-releasing intrauterine system and oral medroxyprogesterone acetate in the treatment of idiopathic heavy menstrual bleeding...
  57. ncbi request reprint Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial
    Alison B Edelman
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA
    Am J Obstet Gynecol 194:425-30. 2006
    ..This study was undertaken to determine whether buccal misoprostol improves cervical preparation achieved with laminaria before second-trimester dilation and evacuation procedures...
  58. ncbi request reprint Cannula fracture in first trimester abortion: a case report and survey of NAF providers
    Alison Edelman
    Department of Obstetrics and Gynecology, UHN 50, Oregon Health and Science University, 3181 SW Sam Jackson, Portland, OR 97201, USA
    Contraception 67:49-51. 2003
    ..25). Cannula fracture is a rare complication of first trimester surgical abortion. Cannula fracture was not found to be associated with resterilization...
  59. pmc Towards germline gene therapy of inherited mitochondrial diseases
    Masahito Tachibana
    Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health and Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, USA
    Nature 493:627-31. 2013
    ..The mtDNA can be efficiently replaced in human oocytes. Although some ST oocytes displayed abnormal fertilization, remaining embryos were capable of developing to blastocysts and producing embryonic stem cells similar to controls...
  60. doi request reprint Sex education and contraceptive use at coital debut in the United States: results from Cycle 6 of the National Survey of Family Growth
    Michelle M Isley
    Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH 43210, USA
    Contraception 82:236-42. 2010
    ..The study was conducted to characterize the relationship between formal sex education and the use and type of contraceptive method used at coital debut among female adolescents...
  61. ncbi request reprint Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women
    Molly Lalor Olsen
    School of Medicine, Oregon Health and Science University, Portland, OR 97239, USA
    Contraception 76:314-8. 2007
    ..To guide research and development, we conducted a survey to determine interest in desired qualities of and intended use of microbicides within the current milieu of contraceptive options...
  62. doi request reprint Body mass index and sexual behavior
    Bliss Kaneshiro
    Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, Hawaii, USA
    Obstet Gynecol 112:586-92. 2008
    ..To characterize the relationship between body mass index and sexual behavior, including sexual orientation, age at first intercourse, ever having had sex with a male partner, number of partners, and frequency of intercourse...
  63. ncbi request reprint IVF patients' attitudes toward multifetal pregnancy reduction
    Eryn B Munks
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    J Reprod Med 52:635-8. 2007
    ..To determine attitudes of in vitro fertilization (IVF) patients toward multifetal pregnancy reduction before and after embryo transfer...
  64. ncbi request reprint Male contraception
    Jeffrey T Jensen
    Department of Obstetrics and Gynecology and Division of Reproductive Sciences, Oregon Regional Primate Research Center, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201 3098, USA
    Curr Womens Health Rep 2:338-45. 2002
    ..A male hormonal method will likely come to market within the next 5 years. Other strategies such as contraceptive vaccines, and inhibitors of spermatogenesis and sperm motility, provide a potential for nonhormonal male contraceptives...
  65. ncbi request reprint Comparison of perinatal grief after dilation and evacuation or labor induction in second trimester terminations for fetal anomalies
    Gary A Burgoine
    Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, USA
    Am J Obstet Gynecol 192:1928-32. 2005
    ..This study was undertaken to compare grief resolution after dilation and evacuation (D&E) or induction of labor (IOL) for second-trimester pregnancy termination...
  66. ncbi request reprint Teaching contraception: an interactive presentation using managing contraception
    Carrie A Cwiak
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, USA
    Am J Obstet Gynecol 191:1788-92. 2004
    ..Our purpose was to determine whether an interactive medical student contraceptive teaching session results in improved knowledge gain or satisfaction when compared with a standard, didactic lecture...

Research Grants4

  1. PDE3 Inhibitors: Selective Blockers of Oocyte Maturation
    Jeffrey Jensen; Fiscal Year: 2004
    ..This approach is expected to provide a foundation for future Phase 1 trials of PDE3 inhibitors in humans. ..
  2. PDE3 Inhibitors: Selective Blockers of Oocyte Maturation
    Jeffrey Jensen; Fiscal Year: 2005
    ..This approach is expected to provide a foundation for future Phase 1 trials of PDE3 inhibitors in humans. ..
  3. PDE3 Inhibitors: Selective Blockers of Oocyte Maturation
    Jeffrey Jensen; Fiscal Year: 2006
    ..This approach is expected to provide a foundation for future Phase 1 trials of PDE3 inhibitors in humans. ..
  4. PDE3 Inhibitors: Selective Blockers of Oocyte Maturation
    Jeffrey Jensen; Fiscal Year: 2007
    ..This approach is expected to provide a foundation for future Phase 1 trials of PDE3 inhibitors in humans. ..